Cure My Disease

Don't miss your cure!

 Log in / Sign up

A remote diet and exercise program aims to help rural cancer survivors shed pounds and lower recurrence risk

NCT ID NCT07723235

Disease control Sponsor: Ohio State University Comprehensive Cancer Center Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting This study
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jul 23, 2026 · Last updated Jul 24, 2026 · Updated 1 time

Summary

This trial tests whether an online, personalized lifestyle program can help rural postmenopausal breast and endometrial cancer survivors lose weight and improve their health. Participants follow a tailored diet and aerobic exercise plan, with mobile health tools to track progress. The study aims to see if such a program is feasible and can lead to meaningful changes in weight, muscle mass, and metabolic health.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
a remote lifestyle program combining aerobic exercise, personalized diet, and mobile health tools
What this could lead to
If successful, this could point toward an accessible, scalable way to improve health outcomes and reduce recurrence risk for rural cancer survivors.
What could go wrong
This is a small, early-stage trial focused on feasibility and preliminary effects, so results may not generalize. Weight loss programs can be hard to sustain long-term.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 90 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Oct 2026

An estimate. Start dates often move.

Expected to finish

Dec 2027

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

40 to 69 years

Sex

Female participants only

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Body mass index (BMI) ≥ 25kg/m\^2 * Age: 40-69 years * 1-5 years post-diagnosis of stage I-III postmenopausal breast cancer or stage I-III endometrial cancer * No known evidence of recurrence (local or distant) or second, primary cancer * No prior history of new other malignancy since their breast or endometrial cancer diagnosis (other than non-melanoma skin cancer) * Not currently participating in any weight loss programs, no personal trainer, and not meeting the physical activity guidelines * No use of any anti-obesity medications in the last 6 months and no plan to start anti-obesity medications during the study period * The ability to walk two blocks without a walker or cane * The ability to speak and read English * Have access to internet with a computer, tablet, or smart phone * Live in rural counties in Ohio and not planning to move away during the study * Are not pregnant, breastfeeding or less than 12-month post-partum and do not plan to become pregnant during the study Exclusion Criteria: * Severe medical conditions, such as unstable cardiovascular disease or digestive disorders, that would preclude physical activity and dietary intervention * Lack of physician clearance if determined necessary by the Physical Activity Readiness Questionnaire (PAR-Q+) * Acute physical limitations for unsupervised exercises at home * Unable to give informed consent

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Anatomic stage I breast cancer ajcc V8 are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

breast cancer carcinosarcoma endometrial carcinoma endometrium neoplasm

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Anatomic stage I breast cancer ajcc V8 Anatomic stage II breast cancer ajcc V8 Anatomic stage III breast cancer ajcc V8 Endometrial carcinoma Stage I uterine corpus carcinoma or carcinosarcoma ajcc V8 Stage II uterine corpus carcinoma or carcinosarcoma ajcc V8 Stage III uterine corpus carcinoma or carcinosarcoma ajcc V8

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The study's own enquiry address

    This study publishes an address for enquiries. See it below .

  2. The places running it

    1 site. The list below names each one and where it is.

  3. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  4. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Study contacts

  • Contact

    Email: •••••@•••••

Locations

  • Ohio State University Comprehensive Cancer Center

    Columbus, Ohio, 43210, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.